Headlines Drive Sharp Moves on Biotechs

Signal Genetics Inc (NASDAQ:SGNL) and OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) are on the move following news

Sep 23, 2015 at 12:24 PM
facebook X logo linkedin


It's been a big day for biotech news, resulting in some sharp moves within the sector. Two stocks worth highlighting are Signal Genetics Inc (NASDAQ:SGNL) and OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), which are headed in opposite directions this afternoon.

SGNL was last seen 8.3% higher at $1.44, after the company inked a deal with an undisclosed business partner to test potential combination therapies for a type of bone marrow cancer called multiple myeloma. This is a dramatic reversal for a stock that was staring at a 71% year-over-year loss heading into today. Earlier, the shares flirted with territory north of $2 for the first time since mid-July.

Today's bull gap may be turning up the heat on Signal Genetics Inc short sellers. Almost 9% of the equity's float is sold short. However, at SGNL's average trading volume, it would take less than two days to buy back these bearish positions.

On the flip side, OGXI has lost nearly one-quarter of its value today, down 24% at $2.22. The catalyst? A failed trial of its pancreatic cancer drug, apatorsen. The steep losses could force analysts to re-evaluate their bullish takes on the drugmaker. All three brokerages tracking OncoGenex Pharmaceuticals Inc have rated it a "buy" or better, and its consensus 12-month price target of $5.30 sits in annual-high territory. A round of downgrades and/or price-target cuts could exacerbate losses.

In separate news, Turing Pharmaceuticals CEO Martin Shkreli confirmed he will lower the price of AIDS treatment Daraprim, following anti-price-gouging pressure from Democratic presidential candidate Hillary Clinton, among others. Shkreli recently jacked up the drug's price more than 55 times, after acquiring it from Impax Laboratories Inc (NASDAQ:IPXL).
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI